Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GTP Nano is a Spanish biotechnology company specializing in the development of advanced drug delivery systems using nanotechnology. The company focuses on the nano-encapsulation of therapeutic agents, including small molecules and nucleic acids, to enhance their stability, solubility, and targeted delivery. Their proprietary platform is designed to overcome biological barriers and improve the safety and efficacy of treatments in oncology, infectious diseases, and ophthalmology. GTP Nano operates primarily through strategic collaborations with pharmaceutical and biotech partners, providing customized formulation solutions for challenging drug candidates. The company's technology is currently being utilized in clinical-stage programs for ocular diseases. By leveraging its expertise in nanomedicine, GTP Nano aims to transform existing therapies into more effective and patient-friendly treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GTP Nano.